Here is a video of a public lecture I gave at National Tsing Hua University (NTHU) in Taiwan.
It begins at around 13:40 (and if I've done it right, the version below should start around there), and the Q&A starts around 1:15:00
I post market design related news and items about repugnant markets. See my Stanford profile. I have a forthcoming book : Moral Economics The subtitle is "From Prostitution to Organ Sales, What Controversial Transactions Reveal About How Markets Work."
Here is a video of a public lecture I gave at National Tsing Hua University (NTHU) in Taiwan.
It begins at around 13:40 (and if I've done it right, the version below should start around there), and the Q&A starts around 1:15:00
Kidney Transplants Save Lives, Cut Taxpayer Costs Lund University
Sweden's kidney exchange programme has been operational since 2018 and will soon be expanded to include the entire EU. The programme has meant that patients' previous waiting times of up to two years have been reduced to just six months.
"Tommy Andersson, Professor of Economics at Lund University School of Economics and Management, never imagined his research would one day lead to this-but his joy, pride, and commitment are unmistakable.
"Thirteen years ago, we began the planning phase in Sweden, and in 2019 we expanded to Denmark, and later to Finland, Iceland, and Norway. The programme is called STEP (Scandiatransplant Exchange Programme). Now, in 2026, there is a consensus on how kidney exchanges should be conducted across the entire EU, and almost all the pieces of the puzzle are in place for us to launch the pilot project during 2026," says Tommy Andersson.
WATCH FILM (in Swedish): "The Economist Saving Lives" -
Tommy Andersson was involved from the start, developing the algorithms that make the kidney exchange programme in Sweden possible. In cases where a family member can donate a kidney, the transplant can occur directly. However, if the donor's kidney does not match the patient, the exchange programme becomes vital. The programme enables matching across Scandinavia and soon across the entire EU."
This morning I zoomed in to the tail end of a quiet celebration in India of a decade of collaboration between the Alliance for Paired Kidney Donation (APKD) and our Indian medical colleagues..
Mike Rees and I both had sent messages of support, and during the call I spoke about my hope that India, which already does the third most kidney transplants in the world, will in the coming decade come to be the country that does the most kidney exchange transplants. That in turn could lead to India eventually becoming a global attractor for patient-donor pairs from countries that don't have lots of transplants or exchanges, to come to India to participate in kidney exchange there.
There remain many obstacles to be overcome before that can happen, but there's been so much progress in India already that those are real possibilities.
Here's the message I emailed to the founding team yesterday:
"Dear Vivek, Pranjal, Mike, Atul and Colleagues: It’s amazing that the collaboration between the Institute of Kidney Diseases and Research Center at the Dr. H L Trivedi Institute of Transplantation Sciences, and the Alliance for Paired Donation is entering its second decade. It’s been thrilling for me to observe the progress that you have made. I recall vividly meeting Dr. Trivedi in 2019 in his hospital room, and I was later deeply honored to deliver The Dr H.L. Trivedi Oration at the ISOT Meeting in 2022. I’ve learned so much from Vivek, and I will never forget watching Pranjal perform a robotic surgery. And it was memorable that you both were able to visit us at Stanford for the kidney summit organized by APKD and Stanford Impact Labs.
"Seeing what you have accomplished has been one of the highlights of my career in market design. It’s good that we’re all still young, since I’m looking forward to the next decade of accomplishment in India."
#########
Here's Mike's message:
"Mike Rees on the 10-year anniversary of IKDRC and APKD working together
"I remember the first time I met Vivek in 2016 at the TTS meeting in Hong Kong. Vivek received the “International Transplantation Science Mentee-Mentor” Award at the TTS 2016 Congress in Hong Kong. The award recognized his work on "Impact of Single Center Kidney Paired Donation Transplantation to Increase Donor Pool in India," completed under the mentorship of Prof. H.L. Trivedi and Prof. P.R. Shah. I remember meeting Vivek, Dr. PR Shah and Pranjal at the award ceremony and thinking about how wonderful it would be if we could work together. I imagined harnessing their great passion of helping patients through kidney transplantation and paired exchange and combining that with the APKD’s powerful software employing Al Roth’s Nobel Prize winning algorithm. While in Hong Kong, Vivek and I went to dinner at my first vegetarian restaurant and there we agreed to work together to try to help expand kidney exchange in India.
"Three years later I travelled to Ahmedabad in May of 2019 with Alvin Roth for the ISOT Mid-term meeting. During that trip, Al and I watched Pranjal do a retroperitoneal donor nephrectomy and a robotic kidney transplantation. It was my first time seeing a robotic kidney transplant and it was so amazing. I met Dr. Himanshu Patel on that trip and I also had the honor of visiting Dr. HL Trivedi and his wife with Vivek. What a legacy Dr. Trivedi has left and I am so proud that APKD has been able to work together with Vivek, Himanshu, Pranjal and all the members of the IKDRC team to extend his wonderful vision.
"Since that meeting in Hong Kong, I have now made 12 trips to India and have become a big fan of Indian food and diversity of Indian culture. I have been so impressed with the passion and commitment of doctors across India, but none more so than at IKDRC. Along the way I have been fortunate to have been joined by Atul Agnihotri, Shridhar Hanchinal, and Trilly Mathew to expand our work in India. We are so grateful for the amazing example the IKDRC team has demonstrated in terms of what is possible when hard work and technology come together to saves the lives of patients with kidney disease. It is truly a joy to celebrate today with you our tenth anniversary of the work between IKDRC and APKD as we commemorate all that we have accomplished together!"
########
Over the last decade I've blogged many times in connection with transplant progress in India. Here's a selection related to this ten-year anniversary:
Wednesday, January 13, 2016 77 Kidney Exchange transplants in 2015 at one transplant center in India
Friday, April 14, 2017 A transplant center in India has done 300 kidney exchange transplants
Wednesday, May 3, 2017 Mike Rees in India to help remove obstacles to kidney exchange
Tuesday, May 21, 2019 Robot-assisted kidney transplantation in Ahmedabad, India.
Wednesday, February 3, 2021 Non-Simultaneous Kidney Exchange Cycles in India: new design, in Transplant International by Kute and Rees et al.
Thursday, October 13, 2022 The Dr H.L. Trivedi Oration at the Indian Society of Transplantation (ISOT) Meeting 2022
Tuesday, February 27, 2024 Stanford Impact Labs announces support for kidney exchange in Brazil, India, and the U.S.
Thursday, August 7, 2025 Stanford conference on extending kidney exchange
Kimberly D. Krawiec and Alvin E. Roth, “WHO Says Countries Should Be Self-Sufficient In (Unremunerated) Organs And Blood,” in James Stacey Taylor and Mark J. Cherry, eds., Markets in Human Organs for Transplantation: Controversy and Contention., Routledge, November 2025 (open source) https://www.taylorfrancis.com/reader/download/5885e1ba-c9af-4547-941c-821a2afaa7ee/chapter/pdf?context=ubx
From the introduction:
[The nonremuneration principle] is only half of a WHO policy, broadly accepted around the world, that mandates both national (or sometimes only regional) self-sufficiency and an absence of remuneration for both blood products and transplantable organs (hereafter, the “twin principles”) (WHO 2009, 2023). This self-
sufficiency mandate, though less examined than the ban on remuneration, presents a real hurdle to progress in transplantation, especially for smaller and low and middle income (LMIC) countries.
"WHO’s insistence on self-sufficiency inhibits cooperative kidney
exchange efforts (as well as other innovations) among countries that
would benefit all concerned, especially the LMIC that the policy is purportedly designed to help. As will be discussed, the policy’s effect on blood products, especially when combined with the no remuneration rule, is even more stark – no country that fails to compensate donors is self-sufficient in plasma collection and few LMIC collect sufficient supplies of whole blood.
"This chapter critiques these twin principles, making several central points. In Section 2.2, we discuss the twin principles as applied to blood products, noting the particularly pernicious effects on plasma supply and availability, especially in poorer nations. In Section 2.3, we turn to transplantation, emphasizing the numerous benefits of international cooperation and cross-border transplantation – benefits that would be undermined by self-sufficiency, especially in smaller countries and those without well-developed domestic exchange programs. We illustrate this point with examples drawn from several noteworthy instances of cross-border kidney exchange.
"In Section 2.4, we argue that the current discourse around remuneration and organ donation is frequently overdramatic and unhelpful. Although nearly every effort to increase organ donation and transplantation presents ethical challenges, not every such effort amounts to “trafficking” or “a crime against humanity.” These labels stifle helpful deliberation, progress, and consensus. Section 2.5 concludes with recommendations for a saner approach to the scarce resources of blood products and transplantable organs – one that is focused on international cooperation, rather than self-sufficiency; evidence-based policies, rather than a reliance on decades-old
assumptions and understandings; and the use of pilot studies and trials to test the ethics, safety, and efficacy of incentives in various settings."
######
Here's the book:
Here's a paper reporting on the experience of four cross-border kidney exchange programs, whose experience teaches an important lesson. In particular (see the figure below), one of the programs is run by Spain, Italy and Portugal, whose total population of approximately 118 million people is far larger than the combined population of the other three*, but manages to do less than 5% of the total cross-border exchanges, far fewer than any of the others. Despite its size, the Spain-Italy-Portugal program only tries to match hard-to-match patient-donor pairs with other hard-to-match pairs, unlike the other three programs.
International Kidney Paired Donation Programs: Evolution and Practices of 4 Large Collaborations
Klimentova, Xenia PhD1; DomÃnguez-Gil, Beatriz MD, PhD2; Viana, Ana PhD1,3; Manlove, David PhD4; Andersson, Tommy PhD5; Ashkenazi, Tamar RN, PhD6; Berlakovich, Gabriela MD7; Böhmig, Georg A. MD8; Burton, Jo RN, PGDip9; Coll, Elisabeth MD, PhD2; Dittmer, Ian FRACP9; Fiaschetti, Pamela MD10; Fronek, Jiri MD, PhD11; Hughes, Peter D. MBBS, PhD12,13; Ivo da Silva, Margarida MD14; Mor, Eytan MD15; Viklický, OndÅ™ej MD, PhD16; Weinreich, Ilse Duus BMLS17; Ferrari, Paolo MD, FRACP18,19
Transplantation ():10.1097/TP.0000000000005602, December 24, 2025. | DOI: 10.1097/TP.0000000000005602
"Plain Language Summary: Kidney paired donation (KPD) programs are organized in various countries to facilitate the donation of kidneys from willing but incompatible donors by matching them with pairs in similar situations. These programs often struggle with an accumulation of difficult-to-match recipients and small pools of incompatible pairs. To address this, several international collaborations have emerged to expand the pool sizes and increase the number of transplants by “exchanging” donors’ kidneys across countries. We identified 4 established international KPD programs, each supported by protocols and agreements signed by the participating parties. Each program is presented separately, detailing its historical establishment, operational aspects, and statistics on pool characteristics and performance. Following this, we provide a comparative analysis of key aspects across the 4 programs. Each program has its unique context and specificities. Even though 3 of 4 collaborations started just before the COVID-19 pandemic, they have collectively facilitated >450 transplants. This underscores the importance of further developing these collaborations to share practices and experiences, and to facilitate more transplants, particularly for difficult-to-match recipients. Three of the 4 presented collaborations are either fully operated or led by European countries. This highlights the crucial role of ongoing international cooperation in the development of KPDs, in particular in Europe. By further promoting collaboration among countries, we can facilitate pan-European exchanges and improve access to live kidney transplants for patients in need.
...
"A fundamental difference between the programs is their collaboration model. STEP, ANZKX, and the Czech-Austrian-Israeli collaboration operate as “merged pool” model, where all participating pairs are combined for joint matching runs. For STEP and ANZKX, no other matching runs are conducted by partners at any level (hospital or national), whereas in the Czech-Austrian-Israeli collaboration, the Austrian and Israeli partners report performing local exchanges whenever compatible pairs are identified.
"In contrast, KEPSAT uses a “sequential pool” model, where national matches are attempted first, and only unmatched pairs are entered into the international pool. It is recognized that the last 2 strategy strategies may lead to a fragmented market, potentially limiting matches for highly sensitized patients, as easier-to-match pairs are removed beforehand."
It's ironic that a program that appears to be intended primarily to help hard-to-match pairs is organized in a way that limits them in this way.
The paper concludes on an optimistic note (with which I fully agree):
"In conclusion, ongoing international cooperation is essential for advancing KPD programs globally. Expanding cross-border exchanges and improving access to kidney transplants can greatly benefit patients worldwide. Additional strategies, such as NDADs, desensitization protocols, and the inclusion of compatible pairs, can further enhance the effectiveness of both national and international programs. Oversight of these initiatives is crucial to safeguarding the welfare of both donors and recipients, as well as to maximizing the success rates of kidney transplants.
"Looking ahead, new initiatives, and projects, funded by international health organizations, such as the European Kidney Paired Exchange Programme project (https://www.hnbts.hu/euro-kep/project), funded by EU4Health and starting in November 2024, aim to expand global collaboration among KPD programs, building on and strengthening existing partnerships. This increased international cooperation is expected to create additional opportunities for patients in need of kidney transplants worldwide, making life-saving transplants accessible to more individuals regardless of their geographic location."
########
Earlier: Portuguese transplant docs noted the problem and argued for more global kidney exchange:
#########
*Notes on population:
Spain: 49 million; Italy 59 million; Portugal 10 million ; KEPSAT total pop = approx 118 million
Australia 28 million; NZ 5 million: ANZKX total pop approx 33 million
Austria: 9 million, Czech Republic 11 million, Israel 10 million: AT-CZ-IL total 30 million
Sweden: 11 million; Norway: 6 million; Denmark 6 million; Finland 6 million: STEP total approx 29 mil
It's Wednesday morning in Cairo, and here's today's conference schedule, which will include discussion of (and voting on) global cooperation in transplantation. (See my earlier post for context.)
| 8:00 AM
08:30 AM |
Opening Session of Ethical Consensus
Global Consensus on Emerging Ethical Frontiers in Transplantation: |
HALL A |
|---|---|---|
| Strategic Co-Leaders
(Alphabetical) |
Alvin E. Roth (Stanford University, USA)
John Fung (University of Chicago, USA) Mark Ghobrial (Methodist Hospital, Houston, USA) Osama A Gaber (Methodist Hospital, Houston, USA) Sandy Feng (UCSF, USA) Valeria Mas (University of Maryland, USA) |
|
| Chairs
(Alphabetical) |
Ahmed Elsabbagh (University of Pittsburgh, USA)
Medhat Askar (Baylor University, USA) Mohamed Ghaly (Hamad Bin Khalifa University, Qatar) Mohamed Hussein (National Guard Hospital, KSA) |
|
| Scientific Committee
(Alphabetical) |
Abdul Rahman Hakeem (King’s College Hospital, UK)
Dieter Broering (KFSHRC, KSA) Hermien Hartog (Groningen, the Netherlands) Hosam Hamed (Mansoura University, Egypt) Manuel Rodriguez (Universidad Nacional Autónoma de México, Mexico) Matthew Liao (Center for Bioethics, New York University, USA) Nadey Hakim (King’s College, Dubai, UAE) Stefan Tullius (Harvard Medical School, USA) Varia Kirchner (Stanford University, USA) Wojciech Polak (Erasmus Medical Center, Rotterdam, the Netherlands)
|
|
| Leadership of Jury Committee
(Alphabetical) |
Chair: John Fung (University of Chicago, USA)
Vice-Chairs
|
|
| 08:30 AM
09:30 AM |
State of Art Lecture (1, 2) | HALL A |
| Chairpersons (Alphabetical) |
Mahmoud El-Meteini (Ain Shams University, Egypt)
Mehmet Haberal (Baskent University, Turkey) Sandy Feng (UCSF, USA) |
|
| 08:30 AM 09:00 AM |
From Dr. Starzl to the Future: The Evolution of Transplantation and the Call to Continue the Journey
John Fung (University of Chicago, USA) |
|
| 09:00 AM 09:30 AM |
Organ Transplant Ethics: How Technoscientific
Developments Challenge Us to Reaffirm the Status of the Human Body so as
to Navigate Innovation in a Responsible Manner Hub A.E. Zwart (Erasmus University Rotterdam, Netherlands) |
|
| 09:30 AM
11:00 AM |
Working Group 1: | HALL A |
| Chairpersons (Alphabetical) |
Ali Alobaidli (Chairman of UAE National transplant committee)
Hermien Hartog (Groningen, The Netherlands) Khalid Amer (Military Medical Academy, Egypt) Lloyd Ratner (Columbia University, NY, USA) Thomas Müller (University Hospital Zurich, Switzerland) |
|
| 09:30 AM 09:50 AM |
Keynote Lecture: Xenotransplantation: Scientific Milestones, Clinical Trials, Risks, and Opportunities Jay Fishman (MGH, USA) |
|
| 09:50 AM 11:00 AM |
WG1 Presentation & Panel Voting
|
|
| 11:00 AM
11:30 AM |
Coffee Break | |
| 11:30 AM
01:00 PM |
Working Group 2: | HALL A |
| Chairpersons (Alphabetical) |
Daniel Maluf (University of Maryland, USA)
Karim Soliman (University of Pittsburgh, USA) Marleen Eijkholt (Leiden University Medical Centre, Netherlands) Refaat Kamel (Ain Shams University, Egypt) Varia Krichner (Stanford University, USA) |
|
| 11:30 AM 11:50 AM |
Keynote Lecture: Smart Transplant: How AI & Machine Learning Are Shaping the Future Dorry Segev (NYU Langone, USA) |
|
| 11:50 AM 01:00 PM |
WG2 Presentation & Panel Voting
|
|
| 01:00 PM
02:30 PM |
Working Group 3: | HALL A |
| Chairpersons (Alphabetical) |
Ahmed Marwan (Mansoura University, Egypt)
Ashraf S Abou El Ela (Michigan, USA) Mostafa El Shazly (Cairo University, Egypt) Peter Abt (UPenn, USA) Philipp Dutkowski (University Hospital Basel, Switzerland) |
|
| 01:00 PM 01:20 PM |
Keynote Lecture: Ischemia-Free Transplantation: A New Paradigm in Organ Preservation and Transplant Medicine Zhiyong Guo (The First Affiliated Hospital of Sun Yat-sen University, China) |
|
| 01:20 PM 02:30 PM |
WG3 Presentation & Panel Voting
|
|
| 02:30 PM
03:30 PM |
Lunch Symposium | HALL B |
| 03:30 PM
05:00 PM |
Working Group 4: | HALL A |
| Chairpersons (Alphabetical) |
David Thomson (Cape Town University, South Africa)
Lucrezia Furian (University Hospital of Padova, Italy) May Hassaballa (Cairo University, Egypt) Abidemi Omonisi (Ekiti State University, Nigeri) Vivek Kute (IKDRC-ITS, Ahmedabad, India) |
|
| 03:30 PM 03:50 PM |
Keynote Lecture: Framing the Conversation: Ethical considerations at the foundation for global transplant collaboration Marleen Eijkholt (Leiden University Medical Centre, Netherlands) |
|
| 03:50 PM 05:00 PM |
WG4 Presentation & Panel Voting
|
|
| 05:00 PM
05:30 PM |
Closing Session of Ethical Consensus
Global Consensus on Emerging Ethical Frontiers in Transplantation: |
HALL A |
| Strategic Co-Leaders
(Alphabetical) |
Alvin E. Roth (Stanford University, USA)
John Fung (University of Chicago, USA) Mark Ghobrial (Methodist Hospital, Houston, USA) Osama A Gaber (Methodist Hospital, Houston, USA) Sandy Feng (UCSF, USA) Valeria Mas (University of Maryland, USA) |
|
| Chairs
(Alphabetical) |
Ahmed Elsabbagh (University of Pittsburgh, USA)
Medhat Askar (Baylor University, USA) Mohamed Ghaly (Hamad Bin Khalifa University, Qatar) |
|
| 05:10 PM 05:30 PM |
State of Art Lecture (3): Reflections from a Transplant Pioneer: Ethics, Policy, and the Future of Global Collaboration Ignazio R. Marino (Thomas Jefferson University, Italy/USA) | |
Some coffee cups should naturally come in pairs, so that you have one for a friend in need. (These recently arrived in the mail, from Laurie Lee)
| Better to exchange kidneys than bombs |
I was quoted as having said that to Marco della Cava, the USA Today reporter who wrote about the first kidney exchange between Israel and the UAE.
“Better to exchange kidneys than bombs,” says Roth, adding that using computers to search the world for medical solutions radically increases the chances of patients getting help. “International boundaries are artificial markers. Kidney disease doesn’t care about that.”